Primary objective: * To identify a biomarker or biomarker-set for the adverse metabolic effects of various doses of prednisolone treatment. Secondary objectives: * To describe the PK of prednisolone and PD of a series of biomarkers. * To identify biomarkers that reflect side effects of prednisolone. * To elucidate part of the mechanisms by which prednisolone induces metabolic changes.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Enrollment
72
Oral administration, once daily, for 15 days
Oral administration
To identify a biomarker or biomarker-set for adverse metabolic effects of various doses of prednisolone
Time frame: Day 1 and day 15
To describe the PK of prednisolone and PD of a series of biomarkers
Time frame: Day 1 and day 15
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.